Related Experiment Video

Updated: Sep 15, 2025

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

2.9K

Editor's Note: FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the

Nu Zhang, Xinjian Wu, Lixuan Yang

    Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
    |July 15, 2025
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Evaluating In Vitro DNA Damage Using Comet Assay
    10:43

    Evaluating In Vitro DNA Damage Using Comet Assay

    Published on: October 11, 2017

    38.1K
    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    21.5K

    Related Experiment Videos

    Last Updated: Sep 15, 2025

    A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
    05:29

    A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

    Published on: March 28, 2021

    2.9K
    Evaluating In Vitro DNA Damage Using Comet Assay
    10:43

    Evaluating In Vitro DNA Damage Using Comet Assay

    Published on: October 11, 2017

    38.1K
    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
    12:55

    Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

    Published on: February 16, 2015

    21.5K

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    4.6K
    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    4.6K

    Articles linked to this work by shared authors, journal, and citation graph.

    Meningeal blood vessel blockage enhances anti-glioblastoma immunity.

    Cell·2026

    Pan-cancer human brain metastases atlas at single-cell resolution.

    Cancer cell·2025

    TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism.

    The Journal of clinical investigation·2025

    Protocol for generating brain metastatic tumor cells through repeated intracardiac injections in mice.

    STAR protocols·2024

    Lnc-H19-derived protein shapes the immunosuppressive microenvironment of glioblastoma.

    Cell reports. Medicine·2024

    Distinct roles of TREM2 in central nervous system cancers and peripheral cancers.

    Cancer cell·2024

    Pancreatic Cancer KRAS Breakthrough: Drug Graveyard No More.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Topoisomerase-Based CDH17 Antibody Drug Conjugates Overcome P-gp Resistance but Undergo Target Mediated Clearance in Colorectal Cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Progress in Clinical Care and Research for Li-Fraumeni Syndrome: Perspectives from the 7th Li-Fraumeni Syndrome Association REACH Symposium.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Endotrophin is a circulating fibroinflammatory biomarker associated with treatment response in human metastatic ER+ breast cancer.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Type II ROS1 Inhibition Overcomes Type I Inhibitor Resistance in ROS1 Fusion-Positive Lung Cancers: A Phase II Trial of Cabozantinib.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Long-term outcomes of modified-intensity lenalidomide, bortezomib and dexamethasone (RVD-lite) in transplant-ineligible multiple myeloma: final report of a phase II trial.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us